The risk of opportunistic infection in the cardiac transplant patient
is determined by the interaction between the epidemiologic exposures t
hat the patient encounters and the patient's net state of immunosuppre
ssion. The epidemiologic exposures include those encountered in both t
he community and the hospital, with the latter being more important as
they usually occur at a point in time when the patient's net state of
immunosuppression is at its highest. The net state of immunosupressio
n is a complex function whose major determinants are the immunosuppres
sive program and the presence or absence of infection with a group of
immunomodulating viruses, particularly cytomegalovirus. Strategies for
preventing opportunistic infection in this patient population are bas
ed on the following factors: technically impeccable surgery, precisely
managed immunosuppression, environmental protection (particularly in
the hospital), and the use of preventative antimicrobial strategies. T
hese last are of two types, prophylactic and preemptive. The key point
in both these approaches is to link the preventative strategy to the
intensity of the immunosuppressive program and to target the antimicro
bial program to the time period and patient group at greatest risk For
most opportunistic infections this is the time period 1 to 6 months a
fter transplantation (when viral infections are prevalent), and the sm
all group of patients more than 6 months after transplantation who are
chronically overimmunosuppressed because of rejection.